Mean Platelet Volume and Its Relation to Risk Stratification of Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- Status
- RECRUITING
- Phase
- PHASE2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- Status
- RECRUITING
- Phase
- PHASE2
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948
- Status
- TERMINATED
- Phase
- PHASE2
Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study
- Status
- RECRUITING
- Phase
- N/A
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
Muscle Dysfunction in Patients With Haematological Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
BMS-986253 in Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
- Status
- COMPLETED
- Phase
- NA